Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Strack

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American College of Cardiology|May 5, 2012
Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9Michelle Melone, Larissa Wilsie, Oksana Palyha, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 23, 2011
The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemiaFabian Chen, Vic Maridakis, Edward A O'Neill, et al.
Pharmacology|December 5, 2008
Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke modelChristopher Regan, Cherrie Shepherd, Alison Strack, et al.
Progress in Brain Research|August 1, 2006
Design and synthesis of (ant)-agonists that alter appetite and adiposityLex H T Van der Ploeg, Akio Kanatani, Douglas MacNeil, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Journal of Lipid Research|January 26, 2011
Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9Brandon Ason, Samnang Tep, Harry R Davis, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonistsRaman K Bakshi, Qingmei Hong, J T Olson, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Bioorganic & Medicinal Chemistry|December 1, 2010
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher doseEster Carballo-Jane, Zhu Chen, Edward O'Neill, et al.
Journal of Lipid Research|March 19, 2011
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical speciesDavid G McLaren, Timothy He, Sheng-Ping Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American College of Cardiology|May 5, 2012
Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9Michelle Melone, Larissa Wilsie, Oksana Palyha, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 23, 2011
The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemiaFabian Chen, Vic Maridakis, Edward A O'Neill, et al.
Pharmacology|December 5, 2008
Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke modelChristopher Regan, Cherrie Shepherd, Alison Strack, et al.
Progress in Brain Research|August 1, 2006
Design and synthesis of (ant)-agonists that alter appetite and adiposityLex H T Van der Ploeg, Akio Kanatani, Douglas MacNeil, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Journal of Lipid Research|January 26, 2011
Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9Brandon Ason, Samnang Tep, Harry R Davis, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonistsRaman K Bakshi, Qingmei Hong, J T Olson, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2006
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonistsJinlong Jiang, Myle Hoang, Jonathan R Young, et al.
Bioorganic & Medicinal Chemistry|December 1, 2010
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher doseEster Carballo-Jane, Zhu Chen, Edward O'Neill, et al.
Journal of Lipid Research|March 19, 2011
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical speciesDavid G McLaren, Timothy He, Sheng-Ping Wang, et al.
Pageof 2